Global, Expert Analytics to Support Robust Data Requirements
Analytical and Process Development Support at Every Phase of the Project Cycle
The clinical and commercial success of biotherapeutics hinges on developing and supporting scalable and reproducible processes.
Analytics is a decision driver across every phase of a project cycle. At KBI, our deep expertise in analytics covers every stage of a project, from structure prediction and analysis to cell line development to commercial manufacturing - across non-cGMP and cGMP activities. Our extensive process and analytical development capabilities cover all stages, supporting early-stage development efforts through small-scale protein production to fully-integrated, comprehensive process optimization leading to cGMP manufacturing. From process and product characterization to scale-down validation studies and at every step along the way, we take pride in our deep knowledge and experience in the science and practice of biopharmaceutical drug development.
KBI's Phase-Specific Lifecycle Approach to Analytics
KBI employs a phase-specific interdisciplinary lifecycle approach to analytics. Combining cutting-edge technology, close collaboration, and keen insight, we create lasting solutions to analytical challenges that take your project from early-stage samples to highly-purified drug substances.
KBI's full range of biopharma analytical and process development capabilities enables us to take on very early or very late programs with full confidence. With our depth of experience, we can readily develop relevant experimental strategies that lead to the rapid optimization of robust, reliable, and scalable processes. To do so, we rely on:
- High throughput chromatographic screening capabilities
- Complimentary analytical tools to enable rapid progress in process development
